13
Views
5
CrossRef citations to date
0
Altmetric
Original

Clinical implications of serum pepsinogen and progastricsin in Man

Pages 81-96 | Published online: 29 Mar 2011

References

  • Kay J. Aspartic proteinases and their inhibitors. Aspartic Proteinases and Their Inhibitors, V Kostka. Walter de Gruyter, Berlin/ New York 1985; 1–17
  • Foltmann B. Comments on the nomenclature of aspartic proteinases. Aspartic Proteinases and Their Inhibitors, V Kostka. Walter de Gruyter, Berlin/New York 1985; 18–26
  • Tang J. Gastricsin and pepsin. Methods Enzymol 1970; 19: 406–21
  • Foltmann B. Gastric proteinases - structure, function, evolution and mechanism of action. Essays Biochem 1981; 17: 52–84
  • Foltmann B. Purification, structure and activation of pepsinogens. Pepsinogens in Man: Clinical and Genetical Advances, J Kreuning, IM Samloff, JI Rotter, AW Eriksson. Alan R. Liss, New York 1985; 1–13
  • Samloff IM. Pepsinogens I and II: Purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982; 82: 26–33
  • Samloff I M, Taggart R T, Hengels KJ. Molecular variants of human aspartic proteinases. Aspartic Proteinases and Their Inhibitors, V Kostka. Walter de Gruyter, Berlin/ New York 1985; 79–95
  • Foltmann B, Tarasova N I, Szecsi PB. Methods for detection of proteinases: Electrophoretic and immunological comparison of aspartic proteinases of different origins. Aspartic Proteinases and Their Inhibitors, V Kostka. Walter de Gruyter, Berlin/ New York 1985; 491–508
  • Pals G, Westerweld BD. Human pepsinogens: Genetic and clinical aspects. Mur-Kostverloren, AalsmeerNetherland 1986
  • Defize J, Meuwissen S GM. Pepsinogens: An update of biochemical, physiological, and clinical aspects. J Pediatr Gastroenterol Nutr 1987; 6: 493–508
  • Enzyme nomenclature. Recommendations. Eur J Biochem 1978; 116: 1981, 423–35, (Suppl 2)
  • Cornaggia M, Capella C, Riva C, Finzi G Solcia-E. Electron immunocytoche-mical localization of pepsinogen I (PgI) in chief cells, mucous-neck cells and transitional mucous-neck/chief cells of the human fundic mucosa. Histochemistry 1986; 85: 5–11
  • Cornaggia M, Riva C, Capella C, Solcia E, Samloff IM. Subcellular localization of pepsinogen II in stomach and duodenum by the immunogold technique. Gastroenterology 1987; 92: 585–93
  • Sano J, Miki K, Ichinose M, et al. In situ localization of pepsinogens I and II mRNA in human gastric mucosa. Acta Pathol Jpn 1989; 39: 765–71
  • Waalewijn R A, Meuwissen S G, Pals G, Hoefsmit EC. Localization of pepsinogen (A and C) and cellular differentiation of pepsinogen-synthesizing cells in the human gastric mucosa. Eur J Cell Biol 1991; 54: 55–60
  • Hirschowitz BI. Pepsinogen: its origins, secretion and excretion. Physiol Rev 1967; 37: 475–511
  • Hansen O Hart, Aa Johansen, Larsen J K, Pedersen T, Svendsen LB. Relationship between gastric acid secretion, histo-pathology, and cell proliferation kinetics in human gastric mucosa. Gastroenterology 1977; 73: 453–6
  • Armour J, Jennings F W, Murray M, Selman I. Bovine ostertagiasis. Clinical aspects, pathogenesis, epidemiology and control. Helminth diseases of cattle, sheep and horses in Europe, GM Urquhart, J Armour. University Press, Glasgow 1973; 11–22
  • Hazel S L, Lee A, Brady L. Campylobacter pyloridis and gastritis: Association with intercellular spaces and adaption to an environment of mucus as important factors in colonization of the gastric epithelium. Infec Dis 1986; 153: 658–63
  • Samloff I M, Liebman WM. Purification and immunochemical characterization of group II pepsinogens in human seminal fluid. Clin Exp Immunol 1972; 11: 405–14
  • Reid W A, Vongsorasak L, Svasti J, Valler M J, Kay J. Identification of the acid proteinase in human seminal fluid as a gastricsin originating in the prostate. Cell Tissue Res 1984; 236: 697–600
  • Szecsi P B, Halgreen H, Poulsen S S, et al. Demonstration of pepsinogen C in human pancreatic islets. Gut 1987; 28: 1208–14
  • Varis KS. Peptic cells. Pepsinogens in Man: Clinical and Genetical Advances, J Kreuning, IM Samloff, JI Rotter, AW Eriksson. Alan R. Liss, New York 1985; 177–84
  • Hengels K J, Strohmeyer G. Pepsinogens A and C: purification from human gastric mucosa and determination in serum by optimized radioimmunoassays. Z Gastroenterol 1989; 27: 406–11
  • Peetsalu A, Tamm A, Härkönen M, et al. The effect of vagotomy and antrectomy on serum pepsinogens I and II. Scand J Gastroenterol 1990; 25: 455–61
  • Townes P L, Ferrari BT. Pepsinogen 7 as an indicator of neonatal maturity: Preliminary studies. J Pediatr 1972; 80: 15–19
  • Samloff I M, Townes PL. Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum and gastric mucosa. Gastroenterology 1970; 58: 462–9
  • Waldum H L, Jorde R. Renal excretion of and the effect of posture on serum group I pepsinogens. Scand J Gastroenterol 1982; 17: 253–5
  • ten Dam M A, Zwiers A, Crusius J B, et al. Tubular reabsorption of pepsinogen isozymogens in man studied by the inhibition of tubular protein reabsorption with dibasic amino acids. Clin Sci 1991; 80: 161–6
  • Samloff I M, Liebman WM. Radioimmunoassay of group I pepsinogens in serum. Gastroenterology 1974; 66: 494–502
  • Waldum H L, Straume B K, Burhol PG. Radioimmunoassay of group I pepsinogens (PG I) and the effect of food on serum PG I. Scand J Gastroenterol 1979; 14: 241–7
  • Axelsson C K, Damkjaer Nielsen M, Kappelgaard AM. Solid-phase double-antibody radioimmunoassay of pepsinogen I in serum. Clin Chim Acta 1982; 121: 309–19
  • Axelsson C K, Axelsen N H, Svendsen PJ. Purification of pepsinogen I from human urine by means of DEAE-chroma-tography and isotachophoresis. Electrophoresis 1980; 1: 164–67
  • Foltmann B, Axelsen NH. Gastric proteinases and their zymogens. Phylogenetic and developmental aspects. Enzyme regulation and mechanism of action, P Mildner, JB Ries. Pergamon Press, Oxford and New York 1980; 271–80
  • Ichinose M, Miki K, Furihata C, et al. Radio-immunoassay of serum group I and group II pepsinogens in normal controls and patients with various disorders. Clin Chim Acta 1982; 126: 183–91
  • Biemond I, Pals G, Giliams J P, Kreuning J, Peña AS. Enzyme linked immunosorbent assay of pepsinogen I. Pepsinogens in Man: Clinical and Genetical Advances, J Kreuning, IM Samloff, JI Rotter, AW Eriksson. Alan R. Liss, New York 1985; 55–66
  • Biemond I, Jansen J B, Crobach L F, Kreuning J, Lamers C BHW. Radioimmunoassay of human pepsinogen A and pepsinogen C. J Clin Chem Clin Biochem 1989; 27: 19–25
  • Petersen G M, Rotter J I, Samloff IM. Quantitative serum pepsinogen: genetics and relationship to urinary and gastric phenotypes. I. Pepsinogens in Man: Clinical and Genetical Advances, J Kreuning, IM Samloff, JI Rotter, AW Eriksson. Alan R. Liss, New York 1985; 79–90
  • Pals G, Westerveld B D, Défize J, et al. Discrepancies between gastric mucosal and urinary pepsinogen A patterns and in vitro synthesis and secretion of human pepsinogen. Dig Dis Sci 1988; 33: 135–43
  • Axelsson C K, Szecsi P B, Damkjaer Nielsen M. Group I pepsinogens in serum. I. Normal range, age and sex relation, diurnal rhythm, seasonal variation, and distribution in ABO blood groups. Scand J Gastroenterol 1984; 19: 1114–8
  • Chang F Y, Cheng J T, Lee F Y, Wang T F, Lai K H, Lee S D, Tsai YT. Serum pepsinogen I levels in patients with non-ulcer dyspepsia. J Gastroenterol Hepatol 1990; 5: 271–6
  • Perasso A, Testino G, de Angelis P, de Grandi R, Auger C. Chief cell mass in normal gastric mucosa: relationship with serum pepsinogen I. Gastroenterol Clin Biol 1990; 14: 158–62
  • Waldum HL. The influence of nervous and humoral stimulation on serum group I pepsinogens. Pepsinogens in Man: Clinical and Genetical Advances, J Kreuning, IM Samloff, JI Rotter, AW Eriksson. Alan R. Liss, New York 1985; 115–27
  • Tarquini B, Benvenuti M, Cavallini V, Cecchettin M, Romano S, Sensi G. Pepsinogen gastrin mesor ratio: A potential simple marker for gastric secretory function. Chronobiologia 1984; 11: 11–7
  • Tarquini B, Cecchettin M, Cariddi A. Serum gastrin and pepsinogen in shift workers. Int Arch Occup Environ Health 1986; 58: 99–103
  • Pals G, Defize J, Pronk J C, Frants R R, et al. Relations between serum pepsinogen levels, pepsinogen phenotypes, ABO blood groups, age and sex in blood donors. Ann Hum Biol 1985; 12: 403–11
  • Parente F, Lazzaroni M, Sangaletti O, Baroni S, Bianchi-Porro G. Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients. Gut 1985; 26: 1327–32
  • Goldschmiedt M, Barnett C C, Schwarz B E, Karnes W E, Redfern J S, Feldman M. Effect of age on gastric acid secretion and serum gastrin concentrations in healthy men and women. Gastroenterology 1991; 101: 977–90
  • Axelsson C K, Axelsen N H, Szecsi P B, Foltmann B. Determination of pepsin (EC 3.4.23.1) and gastricsin (EC 3.4.23.3) in gastric juice by rocket im-munoelectrophoresis. Clin Chim Acta 1983; 129: 323–31
  • Albillos A, Alvarez Mon M, Rossi I, Gonzalo M A, Marin M C, Abreu L. Different HC1 and pepsinogen I secretion patterns in anatomically defined gastric ulcer subsets. Am J Gastroenterol 1990; 85: 535–8
  • Samloff I M, Secrist D M, Passaro E. The effect of betazole on serum group I levels: studies in symptomatic patients with and without recurrent ulcer after vagotomy and gastric drainage. Gastroenterology 1976; 70: 1007–13
  • Samloff I M, Secrist D M, Passaro E. The effect of betazole on serum group I pepsinogens levels: relationship to gastric acid output in unoperated and postoperative patients. Gastroenterology 1977; 72: 845–8
  • Paimela H, Lalla M, Rasanen V. Serum group I pepsinogens after consecutive stimulations with insulin and pentagas-trin in unoperated duodenal ulcer patients and in duodenal ulcer patients after proximal gastric vagotomy. Scand J Gastroenterol 1984; 19: 52–5
  • Äärimaa M, Härkönen M, Varis K, Inberg M, Karonen S-L. Serum group I pepsinogens during insulin and pentagastrin tests in unoperated and vagotomized duodenal ulcer patients. Scand J Gastroenterol 1987; 22: 956–60
  • ten Kate R W, Tuynman H A, Festen H P, Pals G, Meuwissen SG. Pharmacology of pepsinogen secretion: influence of pentagastrin on pepsinogen secretion in man. Hepatogastroenterology 1990; 37: 124–7
  • Goedhard J G, Biemond I, Giliams J P, Pals J, Kreuning J. Serum pepsinogen I levels: Assessment of gastric acid secretion ?. Pepsinogens in Man: Clinical and Genetical Advances, J Kreuning, IM Samloff, JI Rotter, AW Eriksson. Alan R. Liss, New York 1985; 139–46
  • Samloff I M, Varis K, Ihamaki T, Siurala M, Rotter JI. Serum pepsinogens I and II and gastric acid output: effect of gastritis. Pepsinogens in Man: Clinical and Genetical Advances, J Kreuning, IM Samloff, JI Rotter, AW Eriksson. Alan R. Liss, New York 1985; 129–136
  • Festen H PM, Thijs J C, Lamers C BHV, et al. Effect of omeprazole on serum gastrin and serum pepsinogen I. Gatroenterology 1984; 87: 1031–4
  • Biemond I, Crobach L F, Jansen J B, Lamers CB. Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion. Eur J Clin Pharmacol 1989; 37: 345–9
  • Biemond I, Crobach L F, Jansen J B, Lamers CB. Effect of intermittent administration of omeprazole on serum pepsinogens in duodenal ulcer patients and healthy volunteers. Br J Clin Pharmacol 1990; 29: 465–72
  • Baak L C, Biemond I, Jansen J B, Lamers CB. Repeated intravenous bolus injections of omeprazole: effects on 24-hour intragastric pH, serum gastrin, and serum pepsinogen A and C. Scand J Gastroenterol 1991; 26: 737–46
  • Baak L C, Jansen J B, Biemond I, Lamers CB. Weekend treatment with 20 mg and 40 mg omeprazole: effect on intragastric pH, fasting and postprandial serum gastrin, and serum pepsinogens. Gut 1991; 32: 977–82
  • Défize J, Pals G, Frants R R, Westerveld B D, Festen H PM, Pronk J C, Meuwissen S GM, Eriksson AW. The influence of omeprazole on the synthesis and secretion of pepsinogen in isolated rabbit gastric glands. Biochem Pharmachol 1985; 34: 3693–9
  • Jansen J BMJ, Klinkenberg-Knol E C, Meuwissen S GM, et al. Effect og long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux eso-phagitis. Gastroenterology 1990; 99: 621–8
  • Defize J, Hunt RH. Control of pepsinogen synthesis and secretion in primary monolayer cultures of canine gastric chief cells. Dig Dis Sci 1988; 33: 1583–91
  • Raufman J-P. Gastric chief cells: Receptors and signal-transduction mechanisms. Gastroenterology 1992; 102: 699–710
  • Nakanome C, Akai H, Goto Y. Serum group I pepsinogen levels in patients with peptic ulcer and normal subjects. Tokyo J Exp Med 1983; 139: 151–8
  • Rotter J I, Petersen G, Samloff I M, et al. Genetic heterogeneity of hyperpepsinogenemic I and normopepsinogenemic I duodenal disease. Ann Int Med 1979; 91: 372–77
  • Sumii K, Uemura N, Inbe A., et al. Familial aggregation of duodenal ulcer and an autosomal dominant inheritance of hyperpepsinogenemia I. Hiroshima J Med Sci 1986; 35: 171–5
  • Tarn P KH. Serum pepsinogen I in childhood duodenal ulcer. J Pediatr Gastroenterol Nutr 1987; 6: 904–7
  • Lamers C BHW, Jansen J BMJ, Rotter J I, Samloff IM. Serum pepsinogen I in hereditary hypergastrinemic peptic ulcer syndromes. Pepsinogens in Man: Clinical and Genetical Advances, J Kreuning, IM Samloff, JI Rotter, AW Eriksson. Alan R. Liss, New York 1985; 273–81
  • Samloff I M, Stemmermann G N, Heilbrun L K, Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterol 1986; 90: 570–6
  • McConnell R B, Linaker B D, George J. Genetic markers of duodenal ulcer. Pepsinogens in Man: Clinical and Genetical Advances, J Kreuning, IM Samloff, JI Rotter, AW Eriksson. Alan R. Liss, New York 1985; 245–54
  • Ellis A, McConnell RB. Duodenal ulcer and urinary pepsinogen phenotype. Gastroenterology 1982; 83: 1261–3
  • Samloff I M, Varis K, Ihamäki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 82: 204–9
  • Varis K, Samloff I M, Ihamäki T, Siurala M. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Dig Dis Sci 1979; 23: 187–91
  • Borch K, Axelsson C K, Halgreen H, Damkjaer Nielsen M, Ledin T, Szecsi PB. The ratio of pepsinogen A to pepsinogen C: A sensitive test for atrophic gastritis. Scand J Gastroenterol 1989; 24: 870–6
  • Stemmermann G N, Ishidate T, Samloff I M, et al. Intestinal metaplasia of the stomach in Hawaii and Japan. A study of its relation to serum pepsinogen I, gastrin, and parietal cell antibodies. Am J Dig Dis 1978; 23: 815–20
  • Stemmermann G N, Samloff I M, Nomura A, Walsh JH. Serum pepsinogen I and gastrin in relation to extent and localization of intestinal metaplasia in the surgically resected stomach. Dig Dis Sci 1980; 25: 680–7
  • Sipponen P. Atrophic gastritis as a pre-malignant condition. Ann Int Med 1989; 21: 287–90
  • Nomura AMY, Stemmermann G N, Samloff IM. Serum pepsinogen: as a predictor of stomach cancer. Ann Intern Med 1980; 93: 537–40
  • Westerveld B D, Pals G, Défize J, et al. Qualitative and quantitative determinations of pepsinogen I in gastric cancer and premalignant changes of the stomach. Prog Clin Biol Res 1985; 173: 201–12
  • Westerveld B D, Pals G, Defize J, et al. Pepsinogen A polymorphism in gastric mucosa and urine, with special reference to patients with gastric cancer. Clin Genet 1986; 30: 202–12
  • Miki K, Ichinose M, Kawamura N, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989; 80: 111–4
  • Whitecross D P, Armstrong C, Clark A D, Piper DW. The pepsinogens of the human gastric mucosa. Gut 1973; 14: 850–5
  • Ellis A, Hughes S, McConnell RB. Gastric neoplasms and pepsinogen phe-notypes. Br J Cancer 1982; 46: 289–90
  • Meuwissen S GM, Bosma A, van Donk E, Pals G, Eriksson A W, Meyer C LM. Demonstration of pepsinogen A and C positive cells in the Barrett's esophagus. Gastreoenterol 1986; 90: 1551, abstract
  • Tatematsu M, Saito D, Furihata C, et al. Initial DNA damage and heritable permanent change in pepsinogen isoenzyme pattern in the pyloric mucosae of rats after short-term administration of N-Methyl-N'-nitro-N-nitrosoguanidine. J Natl Cancer Inst 1980; 64: 775–81
  • Tatematsu M, Katsuyama T, Furihata C, Fukushima S, Shirai T, Kato T, Ito N. Cellular differentiation and histogenesis of rat glandular stomach cancers. Jpn J Cancer Res 1990; 81: 760–7
  • Ichinose M, Miki K, Wong R N, et al. Methylation and expression of human pepsinogen genes in normal tissues and their alteration in stomach cancer. Jpn J Cancer Res 1991; 82: 686–92
  • Tatematsu M, Ichinose M, Miki K, Hasegawa R, Kato T, Ito N. Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 1990; 40: 494–504
  • Zwiers A, Crusius B, Pals G, Donker A BJM, Meuwissen S JG, Ten Kate RW. Human pepsinogen A isozymogen patterns in serum and gastric mucosa. Gastroenterology 1990; 99: 1576–80
  • Yamaguchi T, Takahashi T, Yokota T, et al. Urinary pepsinogen I as a tumor marker of stomach cancer after total gastrectomy. Cancer 1991; 68: 906–9
  • Kodama M, Koyama K, Tsuburaya Y, et al. Group I pepsinogen for early detection of gastric cancer recurrence after total gastrectomy. discussion. World J Surg 1990; 14: 94–9; 99–100
  • Pals G, Azuma T, Mohandas T K, et al. Human pepsinogen C (progastricsin) polymorphism: evidence for a single locus located at 6p21.1-pter. Genomics 1989; 4: 137–48
  • Taggart R T, Karn R C, Merrit A D, Yu P L, Conneally PM. Urinary pepsinogen isozymes: a highly polymorphic locus in man. Hum Genet 1979; 52: 227–38
  • Frants R R, Pronk J C, Pals G, et al. Genetics of urinary pepsinogen: a new hypothesis. Hum Genet. 1984; 65: 385–90
  • Taggart R T, Mohandas T K, Shows T B, Bell GI. Variable numbers of pepsinogen genes are located in the centromeric region of human chromosome 11 and determine the high frequency electrophoretic polymorphism. Proc Natl Acad Sci 1985; 82: 6240–4
  • Sogawa K, Fujii-Kuriayma Y, Mizukami Y, Ichihara Y, Takahashi K. Primary structure of human pepsinogen gene. J Biol Chem 1983; 258: 5306–15
  • Kageyama T, Takahashi K. The complete amino acid sequence of monkey pepsinogen A. J Biol Chem 1986; 261: 4395–405
  • Taggart R T, Samloff IM. Characterization of the immunochemical and electrophoretic heterogeneity of group I pepsinogens. Gastroenterol 1987; 92: 143–51
  • Warren J R, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; I: 1273–5
  • Blaser MJ. Gastric Campylobacter -like organisms, gastritis, and peptic ulcer disease. Gastroenterology 1987; 93: 371–83
  • Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterol 1989; 96: 615–25
  • McKinlay A W, Upadhyay R, Gemmell C G, Russell RI. Helicobacter pylori bridging the creditibility gap. Gut 1990; 31: 940–5
  • Rautelin H, Kosunen TU. Helicobacter pylori and associated gastroduodenal diseases. APMIS 1991; 99: 677–95
  • Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991; 324: 1043–8
  • Wyle F A, Tarnawski A, Schulman D, Dabros W. Evidence for gastric mucosal cell invasion by C pylori: an ultrastructural study. J Clin Gastroenterol 1990; 12: 92–8, suppl 1
  • Tytgat G NJ, Axon A TR, Dixon M F, Graham D Y, Lee A, Marshall BJ. Helicobacter pylori Causal agent in peptic ulcer disease? Working Party Reports. World Congresses of Gastroenterology, Sydney 1990; 36–45
  • Loffield R JLF, Willems I, Flendrig J A, Arends JW. Helicobacter pylori and gastric carcinoma. Histopathology 1990; 17: 537–41
  • Parsonnet J, Friedman G D, Daniel M S, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127–31
  • Correa P, Fox J, Fontham E, et al. Helicobacter pylori and gastric carcinoma. Cancer 1990; 66: 2569–74
  • Nomura A, Stemmermann G N, Chyou P-H, Kato I, Perez-Perez G I, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325: 1132–6
  • Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori -induced inflammation. Gastroenterology 1992; 102: 720–7
  • Oderda G, Vaira D, Holton J, Ainley C, Altare F, Ansaldi N. Amoxycillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1989; 1: 690–2
  • Oderda G, Vaira D, Holton J, Dowset J F, Ansald N. Serum pepsinogen I and IgG antibody to Campylobacter pylori in non-specific abdominal pain in childhood. Gut 1989; 30: 912–6
  • Oderda G, Vaira D, Dell'Olio D, et al. Serum pepsinogen I and gastrin concentrations in children positive for Helicobacter pylori. J Clin Pathol 1990; 43: 762–5
  • Oderda G, Vaira D, Holton J, et al. Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci 1991; 36: 572–6
  • Szecsi P B, Dalgaard D, Stakemann G, Wagner G, Foltmann B. The concentration of pepsinogen C in human semen and the physiological activation of zymogen in the vagina. Biol Reprod 1989; 40: 653–9
  • Hengels K J, Halfkann M, Zeidler H, Strohmeyer G. Erkennung und verlaufs-kontrolle spontaner und antiphlogistika-induzierter gastroduodenaler lasionen durch serum pepsinogenbestimmung. Klin Wochenschr 1988; 66: 202, (Suppl 13)., (abstract)
  • Kullich W, Pöllmann G, Zmerekar C, Klein G. Stellenwert der bestimmung von pepsinogen I im serum als scree-ningmethode zur früherkennung gastroduodenal läsionen und als verlaufskontrolle unter der therapie mit nicht-steroi-dalen antirheumatika. Z Rheumatol 1991; 59: 39–45
  • Aabakken L, Axelsson C K, Szecsi PB. Pepsinogen A and C levels in relation to acute NSAID-associated mucosal lesions in healthy volounteers, In preparation
  • Song Y H, Mardh S. The occurrence of gastric and duodenal auto-antibodies in peptic ulcer disease. Acta Physiol Scand 1989; 137: 535–9
  • Mardh S, Song YH. Characterization of antigenic structures in auto-immune atrophic gastritis with pernicious anaemia. The parietal cell H,K-ATPase and the chief cell pepsinogen are the two major antigens. Acta Physiol Scand 1989; 136: 581–7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.